Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Lebwohl during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Evommune, Inc.
- Boehringer Ingelheim International GmbH
- Takeda Pharmaceuticals Of North America, Inc.
- Incyte Corporation
- Mindera
- Celltrion
- Deep Apple Therapeutics
- Facilitation of International Dermatology Education
- Almirall US
- Astrazeneca
- Regeneron Pharmaceuticals, Inc.
- EPI Health
- Oruka Therapeutics
- Foundation for Research and Education in Dermatology
- Galderma
- Dermavant Sciences, Inc
- Bristol-Myers Squibb
- AnaptysBio, Inc
- Seanergy
- Strata
- Castle Biosciences Inc.
- Revolo Biotherapeutics
- IQVIA
- Apogee Therapeutics
- Genentech, Inc.
- Avotres Inc.
- Atomwise
- Verrica
- Arcutis, Inc.
- LEO Pharma A/S
- CorEvitas, LLC
- Pfizer Inc., U.S. Pharmaceuticals Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Lebwohl during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Evommune, Inc.
- Boehringer Ingelheim International GmbH
- Takeda Pharmaceuticals Of North America, Inc.
- Incyte Corporation
- Mindera
- Celltrion
- Deep Apple Therapeutics
- Facilitation of International Dermatology Education
- Almirall US
- Astrazeneca
- Regeneron Pharmaceuticals, Inc.
- EPI Health
- Oruka Therapeutics
- Foundation for Research and Education in Dermatology
- Galderma
- Dermavant Sciences, Inc
- Bristol-Myers Squibb
- AnaptysBio, Inc
- Seanergy
- Strata
- Castle Biosciences Inc.
- Revolo Biotherapeutics
- IQVIA
- Apogee Therapeutics
- Genentech, Inc.
- Avotres Inc.
- Atomwise
- Verrica
- Arcutis, Inc.
- LEO Pharma A/S
- CorEvitas, LLC
- Pfizer Inc., U.S. Pharmaceuticals Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
